Fresenius takes second investment grade rating
Fresenius SE, the German medical services company, received its second investment grade rating this week with a Moody's one notch upgrade on Monday. But there was little movement in the company's bond prices as market participants said the change had long been priced in.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: